- Study reveals that the dazzy app increases nightly CPAP use for people suffering from obstructive sleep apnea (OSA).
- Study was done in partnership with Carmel Hospital’s Sleep Disorder Center.
- The research leverages data from wearables, smartphone sensors, and connected devices, which seamlessly integrate with the dayzz.
dayzz, an AI-based end-to-end digital sleep solution, has released the results of a pilot study that shows the impact of using digital tools for remote sleep care.
Specifically, the results show that people suffering from obstructive sleep apnea (OSA) who use the dayzz app increase their nightly CPAP use by an average of 30 minutes per night.
The study was done in partnership with Carmel Hospital’s Sleep Disorder Center was led by Professor Giora Pillar. It was funded by the Israeli Innovation Authority.
By digitally boosting CPAP use at home, the burden of high-touch sleep apnea management is reduced from an already overwhelmed healthcare system. Importantly, the impact of CPAP use will be more pronounced in specialty care, such as sleep medicine.
Commenting on the new development, Professor Giora Pillar, Director of the Sleep Disorder Clinic at Carmel Hospital said:
By enhancing traditional sleep treatment with remote digital care, patients are actually able to get the comprehensive treatment and ongoing support they need for their sleep disorder. It is a true collaboration between healthcare organizations such as ours and tech innovation, placing the patient and their needs in the center.
Her comments were buttressed by Dr. Mairav Cohen-Zion, Chief Science Officer at dayzz who said:
This unique pilot study emphasized that embedding digital-based solutions in traditional healthcare can provide not only significant value to patients and increased accessibility but also significantly reduce the burden on the healthcare system and enable streamlined processes.
What is obstructive sleep apnea (OSA)
OSA is one of the most common sleep disorders, with an estimated 54 million American adults suffering from mild to severe forms of OSA.
A severe shortage and low accessibility to medical sleep expertise, have rendered many people at risk for sleep apnea unassessed and untreated.
The most common side effect of OSA is extreme daytime sleepiness, which significantly impacts mood and energy levels, family functioning, work performance, and quality of life.
How Continuous Airway Pressure (CPAP) therapy helps
OSA is best treated with Continuous Airway Pressure (CPAP) therapy, but 30-60 percent of patients never use the treatment.
Sleeping with a CPAP device can be challenging, both physically and emotionally, and requires proper, personalized, and continuous support to help integrate the treatment into patients’ life and routines.
Due to limited sleep professionals, even those who are able to receive treatment often abandon the process because they lack adequate support.
By leveraging data from wearables, smartphone sensors, and connected devices, which seamlessly integrate with the dayzz app and into patients’ lives, remote sleep care becomes more accessible and efficient.
This reduces the burden on the patient to input important data and enables a constant adjustment of the treatment plan based on the user’s treatment progress and personal data.
The dayzz app empowers patients to set their own pace, adding a higher level of personalization, making patients more likely to adhere to a sleep plan, and boosting the chances of treatment success.
